{"transactions":[{"id":4636977,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option is fully vested and exercisable."}],"balance_after":46398,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4636976,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":86.74,"value":1561320.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4636975,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-07T20:08:53.000Z","date":"2026-10-05","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":5.35,"value":96300.0,"ownership":{"direct":true},"balance_after":163435,"source":{"system":"sec-edgar","filing":"0001813798-26-000023","document":"wk-form4_1791403730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000023/wk-form4_1791403730.xml","form_type":"4"}},{"id":4632630,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Stock Option (right to buy)","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock Option is fully vested and exercisable."}],"balance_after":64398,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632629,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":95,"price":57.094,"value":5423.93,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.09 to $57.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632628,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":2155,"price":56.654,"value":122089.37,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.065 to $56.955. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145530,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4632627,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-10-03T00:05:54.000Z","date":"2026-10-01","kind":"exercise","planned":true,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"balance_after":147685,"source":{"system":"sec-edgar","filing":"0001813798-26-000021","document":"wk-form4_1790971547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000021/wk-form4_1790971547.xml","form_type":"4"}},{"id":4613691,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":1334,"price":59.521,"value":79401.014,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"shares","element":"transactionShares","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $59.155 to $60.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":145435,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":4613690,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":5459,"price":60.36,"value":329505.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":146769,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":4613689,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Ofc, COO"}}],"security":"Common Stock","published_at":"2026-09-09T21:46:35.000Z","date":"2026-09-04","kind":"sale","planned":false,"acquired":false,"shares":1381,"price":61.16,"value":84461.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"shares","element":"transactionShares","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.95 to $61.57. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":152228,"source":{"system":"sec-edgar","filing":"0001813798-26-000019","document":"wk-form4_1788990392.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000019/wk-form4_1788990392.xml","form_type":"4"}},{"id":1443,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Stock Option is fully vested and exercisable."}],"balance_after":66648,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1442,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1432,"price":61.58,"value":88182.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":153609,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1441,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":303,"price":61.424,"value":18611.472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.34 to $61.48. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":155041,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1440,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":924,"price":60.955,"value":56322.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.22. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":155344,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1439,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":713,"price":61.481,"value":43835.953,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $61.31 to $62.04. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156268,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1438,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"sale","planned":false,"acquired":false,"shares":1537,"price":60.886,"value":93581.782,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $60.29 to $61.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156981,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1437,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-09-01","kind":"exercise","planned":false,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"balance_after":158518,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":1436,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-09-02T23:58:39.000Z","date":"2026-08-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":1273,"price":60.74,"value":77322.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":156268,"source":{"system":"sec-edgar","filing":"0001813798-26-000017","document":"wk-form4_1788393516.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000017/wk-form4_1788393516.xml","form_type":"4"}},{"id":696393,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":false,"shares":2250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Stock Option is fully vested and exercisable."}],"balance_after":68898,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":2250},"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696392,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1389,"price":54.089,"value":75129.621,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $53.935 to $54.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157541,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696391,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":861,"price":53.502,"value":46065.222,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $52.915 to $53.91. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158930,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":696390,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:59:11.000Z","date":"2026-08-03","kind":"exercise","planned":true,"acquired":true,"shares":2250,"price":5.35,"value":12037.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 781 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026."}],"balance_after":159791,"source":{"system":"sec-edgar","filing":"0001813798-26-000015","document":"wk-form4_1785963547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000015/wk-form4_1785963547.xml","form_type":"4"}},{"id":716543,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":false,"shares":516,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Stock Option is fully vested and exercisable."}],"balance_after":71148,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":516},"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716542,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":6,"price":57.82,"value":346.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."}],"balance_after":156760,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716541,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":456,"price":57.473,"value":26207.688,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.695 to $57.59. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":156766,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716540,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":1788,"price":56.03,"value":100181.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $55.60 to $56.595. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157222,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":716539,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T22:25:54.000Z","date":"2026-07-01","kind":"exercise","planned":true,"acquired":true,"shares":516,"price":5.35,"value":2760.6,"ownership":{"direct":true},"balance_after":159010,"source":{"system":"sec-edgar","filing":"0001813798-26-000013","document":"wk-form4_1783376751.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000013/wk-form4_1783376751.xml","form_type":"4"}},{"id":753333,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-03T20:59:15.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":301,"price":50.257,"value":15127.357,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $50.205 to $51.01. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158494,"source":{"system":"sec-edgar","filing":"0001813798-26-000011","document":"wk-form4_1780520351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000011/wk-form4_1780520351.xml","form_type":"4"}},{"id":753332,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-06-03T20:59:15.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1949,"price":49.404,"value":96288.396,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $49.03 to $49.93. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":158795,"source":{"system":"sec-edgar","filing":"0001813798-26-000011","document":"wk-form4_1780520351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000011/wk-form4_1780520351.xml","form_type":"4"}},{"id":796298,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-05-01T21:37:53.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":2250,"price":56.831,"value":127869.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $56.425 to $57.26. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":160744,"source":{"system":"sec-edgar","filing":"0001813798-26-000010","document":"wk-form4_1777671471.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000010/wk-form4_1777671471.xml","form_type":"4"}},{"id":818024,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T20:06:08.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":838,"price":58.932,"value":49385.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $58.74 to $59.215. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the \"Settlement Agreement\") pursuant to a \"domestic relations order\" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On March 25 and 26, 2026, the Reporting Person transferred 962 and 612 shares, respectively, of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings."}],"balance_after":162994,"source":{"system":"sec-edgar","filing":"0001813798-26-000008","document":"wk-form4_1775246763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000008/wk-form4_1775246763.xml","form_type":"4"}},{"id":818023,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T20:06:08.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":1412,"price":58.138,"value":82090.856,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.695 to $58.69. The reporting person will provide upon request to the SEC, the issuer or security holder\nof the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":165406,"source":{"system":"sec-edgar","filing":"0001813798-26-000008","document":"wk-form4_1775246763.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000008/wk-form4_1775246763.xml","form_type":"4"}},{"id":849720,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:16.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":4968,"price":59.16,"value":293906.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $58.74 to $59.575. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":166818,"source":{"system":"sec-edgar","filing":"0001813798-26-000005","document":"wk-form4_1773264193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000005/wk-form4_1773264193.xml","form_type":"4"}},{"id":849719,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:16.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":2427,"price":58.316,"value":141532.932,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $57.725 to $58.715. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":171786,"source":{"system":"sec-edgar","filing":"0001813798-26-000005","document":"wk-form4_1773264193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000005/wk-form4_1773264193.xml","form_type":"4"}},{"id":849718,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-11T21:23:16.000Z","date":"2026-03-09","kind":"tax_withholding","planned":true,"acquired":false,"shares":975,"price":59.32,"value":57837.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated January 29, 2026 were sold by the Reporting Person."}],"balance_after":174213,"source":{"system":"sec-edgar","filing":"0001813798-26-000005","document":"wk-form4_1773264193.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000005/wk-form4_1773264193.xml","form_type":"4"}},{"id":875699,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2026-03-03T01:06:44.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":53566,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/48 of shares subject to the option vest on March 26, 2026, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":53566,"derivative":{"exercise_price":60,"expiration_date":"2036-02-26","underlying":"Common Stock","underlying_shares":53566},"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":875698,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:06:44.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1009,"price":61.98,"value":62537.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":175188,"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":875697,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:06:44.000Z","date":"2026-02-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":898,"price":61.98,"value":55658.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":176197,"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":875696,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:06:44.000Z","date":"2026-02-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":1900,"price":61.74,"value":117306.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":177095,"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":875695,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:06:44.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":5102,"price":61.74,"value":314997.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. The RSUs are fully vested upon the date of grant."}],"balance_after":178995,"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":875694,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-03-03T01:06:44.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":32045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The\nRSUs vest as to 1/4 of the shares subject to the award on September 7, 2026 and 1/8 of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through\neach such date."}],"balance_after":173893,"source":{"system":"sec-edgar","filing":"0001813798-26-000003","document":"wk-form4_1772500000.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379826000003/wk-form4_1772500000.xml","form_type":"4"}},{"id":1044406,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-09-10T20:27:29.000Z","date":"2025-09-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":2759,"price":32.41,"value":89419.19,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the Settlement Agreement\") pursuant to a \"domestic relations order\" as defined in Section 16(a)(12) of the\nSecurities Exchange Act of 1934, as amended. On September 9, 2025, the Reporting Person transferred 1,663 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings."}],"balance_after":141848,"source":{"system":"sec-edgar","filing":"0001813798-25-000005","document":"wk-form4_1757536046.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379825000005/wk-form4_1757536046.xml","form_type":"4"}},{"id":1048850,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:11:36.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1429,"price":31.56,"value":45099.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":146270,"source":{"system":"sec-edgar","filing":"0001813798-25-000004","document":"wk-form4_1757016692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379825000004/wk-form4_1757016692.xml","form_type":"4"}},{"id":1048849,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:11:36.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1587,"price":31.56,"value":50085.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":147699,"source":{"system":"sec-edgar","filing":"0001813798-25-000004","document":"wk-form4_1757016692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379825000004/wk-form4_1757016692.xml","form_type":"4"}},{"id":1048848,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:11:36.000Z","date":"2025-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1270,"price":31.56,"value":40081.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the Settlement Agreement\") pursuant to a \"domestic relations order\" as defined in Section 16(a)(12) of the Securities\nExchange Act of 1934, as amended. On April 1, 2025, the Reporting Person transferred 1,689 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025."}],"balance_after":149286,"source":{"system":"sec-edgar","filing":"0001813798-25-000004","document":"wk-form4_1757016692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000181379825000004/wk-form4_1757016692.xml","form_type":"4"}},{"id":1237390,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":5362,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Option is fully vested and exercisable."}],"balance_after":71664,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":5362},"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237389,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":false,"shares":2638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":2638},"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237388,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-03-04T02:14:29.000Z","date":"2025-02-27","kind":"grant","planned":true,"acquired":true,"shares":72536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"1/48 of shares subject to the option vest on March 27, 2025, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":72536,"derivative":{"exercise_price":74.22,"expiration_date":"2035-02-26","underlying":"Common Stock","underlying_shares":72536},"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237387,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":3015,"price":72.1,"value":217381.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":151916,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237386,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":2085,"price":73.837,"value":153950.145,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $73.51 to $74.41. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":154931,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237385,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"sale","planned":true,"acquired":false,"shares":5915,"price":73.071,"value":432214.965,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $72.50 to $73.47. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":157016,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237384,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":5362,"price":5.35,"value":28686.7,"ownership":{"direct":true},"balance_after":162931,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237383,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-03-03","kind":"exercise","planned":true,"acquired":true,"shares":2638,"price":2.42,"value":6383.96,"ownership":{"direct":true},"balance_after":157569,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237382,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-02-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":1270,"price":73.02,"value":92735.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":154931,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237381,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-02-28","kind":"tax_withholding","planned":true,"acquired":false,"shares":2869,"price":73.02,"value":209494.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs."}],"balance_after":156201,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237380,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-02-28","kind":"grant","planned":true,"acquired":true,"shares":5649,"price":73.02,"value":412489.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. The RSUs are fully vested upon the date of grant."}],"balance_after":159070,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237379,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:14:29.000Z","date":"2025-02-27","kind":"grant","planned":true,"acquired":true,"shares":21726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of Common Stock underlying restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 7, 2025 and 12.5% of the shares every six months thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":153421,"source":{"system":"sec-edgar","filing":"0001649094-25-000039","document":"wk-form4_1741054462.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000039/wk-form4_1741054462.xml","form_type":"4"}},{"id":1237378,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-03-04T02:13:03.000Z","date":"2024-12-31","kind":"gift","planned":false,"acquired":false,"shares":74000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a transfer of ownership of the Issuer's common stock to a charitable remainder trust of which the Reporting Person is not a trustee. This transaction is being reported late due to a delay in receiving the transaction information from the Reporting Person's broker and is being reported promptly upon discovery."}],"balance_after":131695,"source":{"system":"sec-edgar","filing":"0001649094-25-000038","document":"wk-form4_1741054377.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000038/wk-form4_1741054377.xml","form_type":"4"}},{"id":1286317,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-05T00:20:00.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option is fully vested and exercisable."}],"balance_after":2638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-25-000010","document":"wk-form4_1738714793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000010/wk-form4_1738714793.xml","form_type":"4"}},{"id":1286316,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-05T00:20:00.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":20,"price":87.94,"value":1758.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."}],"balance_after":205695,"source":{"system":"sec-edgar","filing":"0001649094-25-000010","document":"wk-form4_1738714793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000010/wk-form4_1738714793.xml","form_type":"4"}},{"id":1286315,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-05T00:20:00.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":2666,"price":86.665,"value":231048.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $86.365 to $87.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":205715,"source":{"system":"sec-edgar","filing":"0001649094-25-000010","document":"wk-form4_1738714793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000010/wk-form4_1738714793.xml","form_type":"4"}},{"id":1286314,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-05T00:20:00.000Z","date":"2025-02-03","kind":"sale","planned":true,"acquired":false,"shares":5314,"price":85.996,"value":456982.744,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $85.32 to $86.295. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":208381,"source":{"system":"sec-edgar","filing":"0001649094-25-000010","document":"wk-form4_1738714793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000010/wk-form4_1738714793.xml","form_type":"4"}},{"id":1286313,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-02-05T00:20:00.000Z","date":"2025-02-03","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":2.42,"value":19360.0,"ownership":{"direct":true},"balance_after":213695,"source":{"system":"sec-edgar","filing":"0001649094-25-000010","document":"wk-form4_1738714793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000010/wk-form4_1738714793.xml","form_type":"4"}},{"id":1317448,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-03T23:07:22.000Z","date":"2025-01-02","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":10638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-25-000002","document":"wk-form4_1735945636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000002/wk-form4_1735945636.xml","form_type":"4"}},{"id":1317447,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-03T23:07:22.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":1161,"price":84.431,"value":98024.391,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $84.315 to $84.55. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":205695,"source":{"system":"sec-edgar","filing":"0001649094-25-000002","document":"wk-form4_1735945636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000002/wk-form4_1735945636.xml","form_type":"4"}},{"id":1317446,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-03T23:07:22.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":5483,"price":83.688,"value":458861.304,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $83.31 to $84.215. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":206856,"source":{"system":"sec-edgar","filing":"0001649094-25-000002","document":"wk-form4_1735945636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000002/wk-form4_1735945636.xml","form_type":"4"}},{"id":1317445,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-03T23:07:22.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":1356,"price":82.877,"value":112381.212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $82.31 to $83.265. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":212339,"source":{"system":"sec-edgar","filing":"0001649094-25-000002","document":"wk-form4_1735945636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000002/wk-form4_1735945636.xml","form_type":"4"}},{"id":1317444,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2025-01-03T23:07:22.000Z","date":"2025-01-02","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":2.42,"value":19360.0,"ownership":{"direct":true},"balance_after":213695,"source":{"system":"sec-edgar","filing":"0001649094-25-000002","document":"wk-form4_1735945636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909425000002/wk-form4_1735945636.xml","form_type":"4"}},{"id":1346198,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-12-04T00:13:57.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":18638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000114","document":"wk-form4_1733271231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000114/wk-form4_1733271231.xml","form_type":"4"}},{"id":1346197,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:13:57.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":1127,"price":94.062,"value":106007.874,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $93.75 to $94.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":205695,"source":{"system":"sec-edgar","filing":"0001649094-24-000114","document":"wk-form4_1733271231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000114/wk-form4_1733271231.xml","form_type":"4"}},{"id":1346196,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:13:57.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":1101,"price":93.061,"value":102460.161,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $92.70 to $93.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":206822,"source":{"system":"sec-edgar","filing":"0001649094-24-000114","document":"wk-form4_1733271231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000114/wk-form4_1733271231.xml","form_type":"4"}},{"id":1346195,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:13:57.000Z","date":"2024-12-02","kind":"sale","planned":true,"acquired":false,"shares":5772,"price":92.068,"value":531416.496,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $91.68 to $92.67. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":207923,"source":{"system":"sec-edgar","filing":"0001649094-24-000114","document":"wk-form4_1733271231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000114/wk-form4_1733271231.xml","form_type":"4"}},{"id":1346194,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-12-04T00:13:57.000Z","date":"2024-12-02","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":2.42,"value":19360.0,"ownership":{"direct":true},"balance_after":213695,"source":{"system":"sec-edgar","filing":"0001649094-24-000114","document":"wk-form4_1733271231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000114/wk-form4_1733271231.xml","form_type":"4"}},{"id":1372167,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Performance Restricted Stock Units","published_at":"2024-11-09T01:48:26.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":35661,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents the target number of shares of Issuer's Common Stock underlying an award of performance restricted stock units (\"PSUs\"). Each PSU represents the contingent right to receive one share of the Issuer's Common Stock. The attainment of the performance vesting condition will be based on the Issuer's percentile rank within a peer group based on total shareholder return (\"TSR\") during a four-year performance period that commenced on November 7, 2024, the Grant Date, subject to the Reporting Person's  continuous service with the Issuer through completion of the performance period. The actual number of shares of the Issuer's Common Stock deliverable with respect to the award varies based on performance and ranges from 0% to 250% of the target number of shares."}],"balance_after":35661,"derivative":{"exercise_price":0,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":35661},"source":{"system":"sec-edgar","filing":"0001649094-24-000107","document":"wk-form4_1731116900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000107/wk-form4_1731116900.xml","form_type":"4"}},{"id":1372166,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Performance Stock Option (right to buy)","published_at":"2024-11-09T01:48:26.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":87481,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As part of a company-wide grant to all eligible employees of the Issuer, on November 7, 2024 (the \"Grant Date\"), the Reporting Person was granted a performance stock option to purchase 87,481\nshares of the Issuer's Common Stock at a per share exercise price of $102.70. The option is subject to (1) a service-based vesting condition (vesting as to one-third of the shares on each of the third, fourth\nand fifth anniversaries of the Grant Date) and (2) a performance-vesting condition (which generally requires that the trading price of the Issuer's Common Stock average, over a one-year period, is at least $154.05 (150% of the Grant Date closing price))."}],"balance_after":87481,"derivative":{"exercise_price":102.7,"expiration_date":"2034-11-06","underlying":"Common Stock","underlying_shares":87481},"source":{"system":"sec-edgar","filing":"0001649094-24-000107","document":"wk-form4_1731116900.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000107/wk-form4_1731116900.xml","form_type":"4"}},{"id":1377750,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":26638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1377749,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":240,"price":108.93,"value":26143.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."}],"balance_after":205695,"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1377748,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":631,"price":108.245,"value":68302.595,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $107.86 to $108.505. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":205935,"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1377747,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":2174,"price":107.202,"value":233057.148,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $106.75 to $107.60. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":206566,"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1377746,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"sale","planned":true,"acquired":false,"shares":4955,"price":106.341,"value":526919.655,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $105.75 to $106.74. The reporting person will provide upon request to the SEC, the issuer or security holder of\nthe issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":208740,"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1377745,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-11-04T23:45:31.000Z","date":"2024-11-01","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":2.42,"value":19360.0,"ownership":{"direct":true},"balance_after":213695,"source":{"system":"sec-edgar","filing":"0001649094-24-000090","document":"wk-form4_1730763923.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000090/wk-form4_1730763923.xml","form_type":"4"}},{"id":1380397,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-29T23:41:44.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":false,"shares":3464,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/48 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter, subject to Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":89876,"derivative":{"exercise_price":20.93,"expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":3464},"source":{"system":"sec-edgar","filing":"0001649094-24-000086","document":"wk-form4_1730245298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000086/wk-form4_1730245298.xml","form_type":"4"}},{"id":1380396,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-29T23:41:44.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":false,"shares":1585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Stock Option is fully vested and exercisable."}],"balance_after":77026,"derivative":{"exercise_price":5.35,"expiration_date":"2030-04-17","underlying":"Common Stock","underlying_shares":1585},"source":{"system":"sec-edgar","filing":"0001649094-24-000086","document":"wk-form4_1730245298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000086/wk-form4_1730245298.xml","form_type":"4"}},{"id":1380395,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-29T23:41:44.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":true,"shares":3464,"price":20.93,"value":72501.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024."}],"balance_after":205695,"source":{"system":"sec-edgar","filing":"0001649094-24-000086","document":"wk-form4_1730245298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000086/wk-form4_1730245298.xml","form_type":"4"}},{"id":1380394,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-29T23:41:44.000Z","date":"2024-10-28","kind":"exercise","planned":false,"acquired":true,"shares":1585,"price":5.35,"value":8479.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024."}],"balance_after":202231,"source":{"system":"sec-edgar","filing":"0001649094-24-000086","document":"wk-form4_1730245298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000086/wk-form4_1730245298.xml","form_type":"4"}},{"id":1393129,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-10-03T20:16:45.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":34638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001649094-24-000076","document":"wk-form4_1727986596.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000076/wk-form4_1727986596.xml","form_type":"4"}},{"id":1393128,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:16:45.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":2339,"price":114.947,"value":268861.033,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.81 to $115.17. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":200646,"source":{"system":"sec-edgar","filing":"0001649094-24-000076","document":"wk-form4_1727986596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000076/wk-form4_1727986596.xml","form_type":"4"}},{"id":1393127,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:16:45.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":3349,"price":114.315,"value":382840.935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $113.805 to $114.755. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":202985,"source":{"system":"sec-edgar","filing":"0001649094-24-000076","document":"wk-form4_1727986596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000076/wk-form4_1727986596.xml","form_type":"4"}},{"id":1393126,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:16:45.000Z","date":"2024-10-01","kind":"sale","planned":true,"acquired":false,"shares":2312,"price":113.415,"value":262215.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $112.805 to $113.78. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":206334,"source":{"system":"sec-edgar","filing":"0001649094-24-000076","document":"wk-form4_1727986596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000076/wk-form4_1727986596.xml","form_type":"4"}},{"id":1393125,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-10-03T20:16:45.000Z","date":"2024-10-01","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":2.42,"value":19360.0,"ownership":{"direct":true},"balance_after":208646,"source":{"system":"sec-edgar","filing":"0001649094-24-000076","document":"wk-form4_1727986596.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000076/wk-form4_1727986596.xml","form_type":"4"}},{"id":1404185,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-18T20:23:29.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":42638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001649094-24-000068","document":"wk-form4_1726691002.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000068/wk-form4_1726691002.xml","form_type":"4"}},{"id":1404184,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-18T20:23:29.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":222,"price":116.96,"value":25965.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The Reporting Person entered into a divorce settlement agreement with his ex-spouse (the \"Settlement Agreement\") pursuant to a \"domestic relations order\" as defined in Section 16(a)(12) of the Securities Exchange Act of 1934, as amended. On September 17, 2024, the Reporting Person transferred 1,312 shares of Vaxcyte, Inc. Common Stock to his ex-spouse pursuant to the Settlement Agreement. Accordingly, the Reporting Person will not report beneficial ownership of or dispositions of the disposed shares in future Section 16(a) filings."}],"balance_after":200646,"source":{"system":"sec-edgar","filing":"0001649094-24-000068","document":"wk-form4_1726691002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000068/wk-form4_1726691002.xml","form_type":"4"}},{"id":1404183,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-18T20:23:29.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":7994,"price":116.137,"value":928399.178,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $115.715 to $116.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":202180,"source":{"system":"sec-edgar","filing":"0001649094-24-000068","document":"wk-form4_1726691002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000068/wk-form4_1726691002.xml","form_type":"4"}},{"id":1404182,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-18T20:23:29.000Z","date":"2024-09-16","kind":"sale","planned":true,"acquired":false,"shares":1784,"price":115.062,"value":205270.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.50 to $115.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the\nissuer, full information regarding the number of shares sold at each separate price."}],"balance_after":210174,"source":{"system":"sec-edgar","filing":"0001649094-24-000068","document":"wk-form4_1726691002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000068/wk-form4_1726691002.xml","form_type":"4"}},{"id":1404181,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-18T20:23:29.000Z","date":"2024-09-16","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":2.42,"value":24200.0,"ownership":{"direct":true},"balance_after":211958,"source":{"system":"sec-edgar","filing":"0001649094-24-000068","document":"wk-form4_1726691002.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000068/wk-form4_1726691002.xml","form_type":"4"}},{"id":1414775,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-05T21:19:30.000Z","date":"2024-09-03","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter."}],"balance_after":52638,"derivative":{"exercise_price":2.42,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001649094-24-000066","document":"wk-form4_1725571164.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000066/wk-form4_1725571164.xml","form_type":"4"}},{"id":1414774,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-05T21:19:30.000Z","date":"2024-09-03","kind":"tax_withholding","planned":true,"acquired":false,"shares":5545,"price":110.15,"value":610781.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F10","text":"Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units. No other shares of common stock subject to the restrictions on transfer set forth in a Lock-Up Agreement dated September 4, 2024 were sold by the Reporting Person."}],"balance_after":201958,"source":{"system":"sec-edgar","filing":"0001649094-24-000066","document":"wk-form4_1725571164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000066/wk-form4_1725571164.xml","form_type":"4"}},{"id":1414773,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-05T21:19:30.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":10,"price":117.025,"value":1170.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."}],"balance_after":207503,"source":{"system":"sec-edgar","filing":"0001649094-24-000066","document":"wk-form4_1725571164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000066/wk-form4_1725571164.xml","form_type":"4"}},{"id":1414772,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-05T21:19:30.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":1195,"price":116.4249,"value":139127.7555,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $116.02 to $117.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":207513,"source":{"system":"sec-edgar","filing":"0001649094-24-000066","document":"wk-form4_1725571164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000066/wk-form4_1725571164.xml","form_type":"4"}},{"id":1414771,"issuer":{"id":1164,"kind":"organization","name":"Vaxcyte, Inc.","symbol":"PCVX"},"owners":[{"id":1169,"kind":"person","name":"Wassil Jim","position":1,"cik":"0001813798","reported_name":"Wassil Jim","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2024-09-05T21:19:30.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":344,"price":115.1458,"value":39610.1552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 1, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted-average price. The shares were sold at prices ranging from $114.97 to $115.75. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":208708,"source":{"system":"sec-edgar","filing":"0001649094-24-000066","document":"wk-form4_1725571164.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1813798/000164909424000066/wk-form4_1725571164.xml","form_type":"4"}}],"next_cursor":"2024-09-05T21:19:30.000000Z,1414771"}